F-STAR THERAPEUTICS INC (FSTX)
US30315R1077 - Common Stock
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -44.75M | -31.28M | -25.62M | -24.10M | -22.85M | |||
| Depreciation Amortization | 672.00K | 642.00K | 1.14M | 360.00K | 290.00K | |||
| Income Taxes - Deferred | N/A | -569.00K | N/A | N/A | N/A | |||
| Change In Working Capital | -6.81M | -4.35M | 1.03M | -810.00K | -1.23M | |||
| Interest Paid | 1.02M | 536.00K | N/A | N/A | N/A | |||
| Taxes Paid | N/A | 276.00K | 120.00K | 30.00K | 0.00 | |||
| Other non cash items | 13.54M | 8.29M | 7.22M | -4.51M | -1.45M | |||
| OPERATING CASH FLOW | -37.91M | -27.27M | -16.23M | -29.06M | -25.24M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -393.00K | -658.00K | -730.00K | -270.00K | -1.97M | |||
| Other Investing Activity | 38.00K | 15.00K | 14.78M | 23.77M | -23.13M | |||
| INVESTING CASH FLOW | -355.00K | -643.00K | 14.05M | 23.50M | -25.10M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 9.85M | 850.00K | 20.00M | N/A | |||
| Stock Issued/Repurchased | 3.36M | 78.35M | 15.00M | 10.00K | 41.17M | |||
| Other Financing Activity | -123.00K | -92.00K | N/A | -460.00K | N/A | |||
| FINANCING CASH FLOW | 3.24M | 88.10M | 15.85M | 19.54M | 41.17M | |||
| Exchange Rate Effect | -451.00K | -166.00K | -50.00K | N/A | N/A | |||
| CHANGE IN CASH | -35.48M | 60.02M | 13.62M | 13.98M | -9.17M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -37.91M | -27.27M | -16.23M | -29.06M | -25.24M | |||
| Capital Expenditure | -393.00K | -658.00K | -730.00K | -270.00K | -1.97M | |||
| FREE CASH FLOW | -38.31M | -27.93M | -16.96M | -29.33M | -27.21M | |||
All data in USD